Plants traits introduced by Crispr gene editing will be subject to the same lengthy regulatory process as 1980s-style genetically modified organisms containing genes from other species, Europe’s highest court rules
Call them what you will: change makers, thought leaders, people who get stuff done. This is the Science|Business guide to those with the most influence over the size and shape of the EU’s next research programme
UK doctors think Britain’s exit from the European Union will be very bad for the NHS, reveal the results of a study from UCL, the London School of Hygiene & Tropical Medicine (LSHTM) and Queen Mary University of London.
At the Euroscience Open Forum conference, a Bulgarian medical start-up demonstrates the potential - and the challenges - of getting health systems to focus on preventing disease, rather than responding when it strikes
The UK decision to leave the EU cuts at science’s core ethos of openness. As exit negotiations lurch along, researchers from across Europe are yet to spot a bright side to losing such an important science partner
Carlos Moedas bemoans erosion of trust in science and fact that truth is now seemingly immaterial. “Politicians lie, people still vote for them, how crazy is that?” he tells the Euroscience Open Forum meeting in Toulouse
An Antimicrobial Resistance (AMR) Accelerator Programme is part of new IMI Calls for proposals, along with topics on brain disorders, immune-mediated diseases clinical trial design, medicines safety, and blockchain technologies.